Zobrazeno 1 - 10
of 144
pro vyhledávání: '"Myeong Jun Song"'
Autor:
Seok-Hwan Kim, Myeong Jun Song
Publikováno v:
The Korean Journal of Gastroenterology, Vol 83, Iss 5, Pp 205-207 (2024)
Externí odkaz:
https://doaj.org/article/459f13f9808b4a0e998def3dc38d87cc
Autor:
Heechul Nam, Jaejun Lee, Ji Won Han, Soon Kyu Lee, Hyun Yang, Hae Lim Lee, Pil Soo Sung, Hee Yeon Kim, Seok-Hwan Kim, Myeong Jun Song, Jung-Hyun Kwon, Chang Wook Kim, Soon Woo Nam, Si Hyun Bae, Jong Young Choi, Seung Kew Yoon, Jeong Won Jang
Publikováno v:
Liver Cancer, Pp 1-13 (2023)
Introduction: Despite the emergence of atezolizumab and bevacizumab (A + B) as standard first-line systemic therapy for unresectable hepatocellular carcinoma (HCC), a comprehensive understanding of the clinical significance of immune-related adverse
Externí odkaz:
https://doaj.org/article/aa5ebb1ab0bb46b69d1bb99950fbf6fd
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
Background/AimsTransarterial chemoembolization (TACE) is widely performed as a major treatment for hepatocellular carcinoma (HCC) patients, and there is a need to stratify patients for whom the most benefit from the treatment. This study aimed to dev
Externí odkaz:
https://doaj.org/article/c2cbe1308e2b49b3bfac1ac8b496db4d
Autor:
Ji Won Han, Pil Soo Sung, Jae-Sung Yoo, Hee Sun Cho, Soon Kyu Lee, Hyun Yang, Ji Hoon Kim, Heechul Nam, Hae Lim Lee, Hee Yeon Kim, Sung Won Lee, Do Seon Song, Myeong Jun Song, Jung Hyun Kwon, Chang Wook Kim, Si Hyun Bae, Jeong Won Jang, Jong Young Choi, Seung Kew Yoon
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
BackgroundAtezolizumab+bevacizumab (AB) and lenvatinib have been proposed as first-line treatment options for patients with advanced hepatocellular carcinoma (HCC), but comparative efficacy and associated factors are controversial.Materials and metho
Externí odkaz:
https://doaj.org/article/a5bacfced7d94a80ad9b89efcedec63c
Autor:
Soon Kyu Lee, Sung Won Lee, Hae Lim Lee, Hee Yeon Kim, Chang Wook Kim, Do Seon Song, U Im Chang, Jin Mo Yang, Sun Hong Yoo, Jung Hyun Kwon, Soon Woo Nam, Seok-Hwan Kim, Myeong Jun Song, Jaejun Lee, Hyun Yang, Si Hyun Bae, Ji Won Han, Heechul Nam, Pil Soo Sung, Jeong Won Jang, Jong Young Choi, Seung Kew Yoon
Publikováno v:
The Korean Journal of Internal Medicine, Vol 37, Iss 6, Pp 1167-1175 (2022)
Background/Aims To evaluate the efficacy and safety of ledipasvir/sofosbuvir (LDV/SOF) therapy in hepatitis C virus (HCV)-infected Korean patients in a real clinical setting. Methods A total of 273 patients who received LDV/SOF therapy between May 20
Externí odkaz:
https://doaj.org/article/324246e4a849422781cf1509de5cce2e
Autor:
Ji Eun Ryu, Myeong Jun Song, Seok-Hwan Kim, Jung Hyun Kwon, Sun Hong Yoo, Soon Woo Nam, Hee Chul Nam, Hee Yeon Kim, Chang Wook Kim, Hyun Yang, Si Hyun Bae, Do Seon Song, U Im Chang, Jin Mo Yang, Sung Won Lee, Hae Lim Lee, Soon Kyu Lee, Pil Soo Sung, Jeong Won Jang, Jong Young Choi, Seung Kew Yoon
Publikováno v:
The Korean Journal of Internal Medicine, Vol 37, Iss 5, Pp 958-968 (2022)
Background/Aims To evaluate the effectiveness and safety of direct acting antivirals (DAAs) available in chronic kidney disease (CKD) patients with hepatitis C virus (HCV) infection in Korea. Methods In a retrospective, multicenter cohort study, 362
Externí odkaz:
https://doaj.org/article/56e49e1477b041b4b68e85e9a5d62527
Autor:
Eileen L. Yoon, Sang Bong Ahn, Dae Won Jun, Yong Kyun Cho, Do Seon Song, Jae Yoon Jeong, Hee Yeon Kim, Young Kul Jung, Myeong Jun Song, Sung Eun Kim, Hyoung Su Kim, Soung Won Jeong, Sang Gyune Kim, Tae Hee Lee
Publikováno v:
The Korean Journal of Internal Medicine, Vol 37, Iss 4, Pp 757-767 (2022)
Background/Aims L-carnitine is potentially beneficial in patients with hepatic encephalopathy (HE). We aimed to evaluate the impact of L-carnitine on the quality of life and liver function in patients with liver cirrhosis and covert HE. Methods We co
Externí odkaz:
https://doaj.org/article/51913821b42a4814a65c68054dc6240d
Autor:
Chieh-Yu Liao, Fanta Barrow, Nanditha Venkatesan, Yasuhiko Nakao, Amy S. Mauer, Gavin Fredrickson, Myeong Jun Song, Tejasav S. Sehrawat, Debanjali Dasgupta, Rondell P. Graham, Xavier S. Revelo, Harmeet Malhi
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
Sphingosine 1-phosphate (S1P) is a bioactive sphingolipid associated with nonalcoholic steatohepatitis (NASH). Immune cell-driven inflammation is a key determinant of NASH progression. Macrophages, monocytes, NK cells, T cells, NKT cells, and B cells
Externí odkaz:
https://doaj.org/article/04fb835c59e14dc881c914ebb1555452
Autor:
Myeong Jun Song, Jong Young Choi
Publikováno v:
Frontiers in Endocrinology, Vol 13 (2022)
Non-alcoholic fatty liver disease (NAFLD) is the most common form of chronic liver disease in the world. It is linked mainly to insulin resistance and metabolic syndrome including obesity and dyslipidemia. In addition, various endocrine dysfunctions
Externí odkaz:
https://doaj.org/article/95319ae70b384bce82969b859a4a380d
Autor:
Myeong Jun Song
Publikováno v:
Gut and Liver, Vol 16, Iss 1, Pp 5-7 (2022)
Background/Aims: Neoadjuvant chemotherapy is increasingly utilized in patients with borderline or locally advanced pancreatic cancer (LAPC). However, the pathologic evaluation of tumor regression is not routinely performed or well established. We aim
Externí odkaz:
https://doaj.org/article/9be2d1742a0e4171a36e81877b412a9e